VL
Vertical Longevity Pharmaceuticals, Inc.
SEC filingBiotechnology · Irvine, CA
Amount raised$110Ksold at filing
Total offering$110K
Investors in the raise5count reported to the SEC
FiledSep 28, 2026first sale Nov 4, 2025
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
David Philip ScieszkaExecutive Officer
Executive officers, directors and promoters as listed on the Form D.